Related Experiment Video
Updated: Mar 17, 2026

Author Spotlight: Enhancing Coronary Artery Revascularization
Published on: September 15, 2023
[DELAYED CORONARY SURGERY FOR THE TREATMENT OF ACUTE MYOCARDIAL INFARCTION WITH ELEVATED ST SEGMENT]
Insights
Delayed transdermal coronary surgery (TCS) is effective for acute myocardial infarction (MI) patients when early treatment is unavailable. This reperfusion therapy strategy reduces complications and mortality in the critical post-MI period.
Area of Science:
- Cardiology and Cardiovascular Surgery
- Interventional Cardiology
- Acute Myocardial Infarction Treatment
Background:
- Early reperfusion therapy (RT) is crucial for acute myocardial infarction (MI) with ST-segment elevation.
- Transdermal coronary surgery (TCS) is often unavailable during the recommended early treatment window.
- Risk stratification is essential to guide reperfusion strategies in MI patients.
Purpose of the Study:
- To develop algorithms for reperfusion therapy prioritizing delayed transdermal coronary surgery (TCS).
- To assess the effectiveness of delayed TCS compared to other MI treatment strategies.
- To evaluate the impact of delayed TCS on overall and cardiovascular mortality in MI patients.
Main Methods:
- Comparative analysis of treatment strategies in 1245 acute ST-segment elevation MI patients (2003-2007).
- Treatment groups included: early TCS, delayed TCS (24-72 hr), thrombolysis without TCS, and conservative therapy.
- Long-term follow-up (5 years) assessed general and cardiovascular lethality in 474 patients.
Main Results:
- Delayed TCS (24-72 hr post-MI) effectively prevents complications and reduces fatal outcomes.
- The effectiveness of delayed TCS was demonstrated even when early intervention was not possible.
- Delayed TCS is a viable option for patients with late admission or transfer from facilities lacking interventional cardiology.
Conclusions:
- Unavailability of early transdermal coronary surgery (TCS) does not preclude its successful delayed application in high-risk acute myocardial infarction (MI) patients.
- Delayed TCS significantly improves outcomes, reducing mortality in both early and late post-infarction periods.
- This strategy offers a critical treatment option for acute MI patients admitted late or transferred from other institutions.
Aim:
To develop algorithms of reperfusion therapy (RT) based on the assessment of the initial risk of death determining the priority use of delayed transdermal coronary surgery (TCS) unavailable in the early period. We compared effectiveness of different strategies for the treatment of 1245 patients with acute myocardial infarction (MI) and elevated ST segment in 2003-2007 including various TCS modalities at recommended time (n = 88), delayed TCS within 24-72 hr after the onset of MI (n = 194), thrombolytic therapy without subsequent TCS (n = 275), and conservative therapy (N = 688). The general and cardiovascular lethality was evaluated among 474 patients 5 years after discharge. The results suggest that unavailability of TCS in recommended time in case of enhanced risk of death does not exclude the possibility of its delayed application. TCS 24-72 hr after the onset of MI prevents complications and the fatal outcome the frequency of which remains high remains high not only in the early but also in the late post-infarction period. Delayed TCS can be effectively used to treat patients in case of their late admission or referral from other hospitals where X-ray endovascular methods for the treatment of acute MI are not used.
More Related Videos
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Angina IV: Management

